The new test has demonstrated an initial 94% sensitivity rate in tumour detection and the test is delivered in under 20 ...

Discover recent research that sheds light on a promising therapeutic strategy for tackling prostate cancer by targeting the ...

Our health is our greatest asset and taking a proactive approach can prevent small issues from becoming big problems. Whether ...

Janux Therapeutics has a robust balance sheet, with $658.1 million in liquid assets and no debt. See why I reiterate my buy ...

An ultrasound test that takes less than 20 minutes could improve the accuracy of prostate cancer diagnosis, scientists say.

Investing.com -- Shares of Vir Biotechnology, Inc. (NASDAQ: VIR) surged 29% following the release of encouraging safety and efficacy data from ongoing dose escalation trials for its dual-masked T-cell ...

A prostate cancer imaging breakthrough could cut waiting times after “extremely encouraging” results in its first clinical ...

Most important note is- surgeries for benign enlargement removes only the center part of the prostate to clear the ...

As we welcome 2025, health experts are urging Australians—particularly those in high-risk age groups—to take charge of their ...

Researchers say they have been encouraged by trials of a new process to detect prostate cancer in men. It is hoped that the ...

Eleos Specialist Hospital has commenced laparoscopic radical prostatectomy (also known as keyhole Surgery for Prostate Cancer ...